Market Place
Sourcing Support
Press release: Sanofi successfully prices USD 3B of bond issue
28 Oct 2025 //
PRESS RELEASE
Zag Bio Emerges With $80M Funding For Tregs Diabetes Candidate
28 Oct 2025 //
FIERCE BIOTECH
Sanofi India Appoints Deepak Arora As Managing Director
27 Oct 2025 //
ECONOMICTIMES
Sanofi`s Dupixent Reaches Quarterly Sales Of €4B For First Time
24 Oct 2025 //
FIERCE PHARMA
Press Release: Q3: Continued Sales And Earnings Progress
24 Oct 2025 //
PRESS RELEASE
Sanofi Drops Toddler RSV Vaccine After Ph. 3 Heads For Failure
24 Oct 2025 //
FIERCE BIOTECH
Sanofi, Medidata Partner to Accelerate Therapy Development
24 Oct 2025 //
PHARMIWEB
Sanofi’s Efdoralprin Alfa Meets Ph2 Endpoints in AATD Emphysema
22 Oct 2025 //
PRESS RELEASE
Sanofi`s $1.7B Bet Beats Csl`s Zemaira In Phase 2 Face-Off
22 Oct 2025 //
FIERCE BIOTECH
Electra shines with $183M fundraise for rare disease trial
22 Oct 2025 //
GLOBENEWSWIRE
Alphamedixtm Phase 2 Data Back New Targeted Alpha Therapy
20 Oct 2025 //
PRESS RELEASE
Sanofi`s Tzield Fast-Tracked For Stage 3 Type 1 Diabetes Review
20 Oct 2025 //
PRESS RELEASE
Sanofi Updates EU Review of Rezurock in Chronic GVHD
17 Oct 2025 //
GLOBENEWSWIRE
Sanofi`s Wayrilz Recommended For EU Approval For thrombocytopenia
17 Oct 2025 //
PRESS RELEASE
Regeneron, Sanofi Receive 1- To 2-Month Priority Review Vouchers
17 Oct 2025 //
FIERCE BIOTECH
Europe`s CHMP Issues Negative Opinion On Sanofi`s Rezurock
17 Oct 2025 //
FIERCE PHARMA
Evoq Therapeutics Signs On With Sanofi In $500M Partnership
17 Oct 2025 //
FIERCE BIOTECH
US FDA Announces Recipients Of National Priority Vouchers
16 Oct 2025 //
REUTERS
Sanofi Discloses Voting Rights & Shares Data - Sep 2025
14 Oct 2025 //
GLOBENEWSWIRE
Expedition Therapeutics Secures $165M In Series A Funding
09 Oct 2025 //
PHARMIWEB
Sanofi $110 M Radioligand Therapy Hits Main Goal in Ph. 2 Trial
09 Oct 2025 //
PRESS RELEASE
Sanofi Inks Pact with Canadian Tech Company to Bring AI to R&D
09 Oct 2025 //
FIERCE BIOTECH
AlphaMedix (212Pb-DOTAMTATE) Meets Ph2 Endpoints In GEP-NET Study
08 Oct 2025 //
PRESS RELEASE
Biovaxys Appoints Former Sanofi Vaccines Executive to Board
08 Oct 2025 //
PR NEWSWIRE
Galderma`s Itch Relief Claims Scratched After Sanofi Complaint
08 Oct 2025 //
FIERCE PHARMA
Novavax Advances Sanofi Partnership With Nuvaxovid® EU Marketing
07 Oct 2025 //
PR NEWSWIRE
Revvity Unveils Initiative For Early Type 1 Diabetes Detection
02 Oct 2025 //
PHARMAWEB
Sanofi Ventures Invests In Quanthealth To Boost AI-Driven Trial
01 Oct 2025 //
BUSINESSWIRE
Novavax Announces Progress On Sanofi Agreement
01 Oct 2025 //
PRESS RELEASE
Star Therapeutics Secures $125m In Series D Funding
30 Sep 2025 //
BUSINESSWIRE
Sanofi Under EU Investigation Over Vaccines
30 Sep 2025 //
REUTERS
Boryung Picks Up Taxotere Rights In Deal Worth Up To $205M
30 Sep 2025 //
FIERCE PHARMA
Sanofi Boosts Ventures With $625m For Biotech And Digital Health
27 Sep 2025 //
PRESS RELEASE
Sanofi Expands Price Cut To $35 Monthly For All Insulin Products
26 Sep 2025 //
FIERCE PHARMA
Immuneering Prices 175M Public Offering, Secures 25M in Placement
25 Sep 2025 //
GLOBENEWSWIRE
Press Release: Availability Of The Q3 2025 Aide Mémoire
24 Sep 2025 //
PRESS RELEASE
Sanofi Launches Ai-Powered Real Skinformation Site
23 Sep 2025 //
PHARMAWEB
Sanofi’s SAR446268 Gets Fast Track for Myotonic Dystrophy Type 1
23 Sep 2025 //
GLOBENEWSWIRE
Sanofi`s Dupixent® For Chronic Spontaneous Urticaria Gains
22 Sep 2025 //
GLOBENEWSWIRE
Sanofi, Regeneron`s Dupixent For Chronic Spontaneous Urticaria
22 Sep 2025 //
GLOBENEWSWIRE
Sanofi`s Oral Ms Drug FDA Action Date Shifted To December
22 Sep 2025 //
BIOSPACE
Update on the US Regulatory Review of Tolebrutinib in MS
22 Sep 2025 //
PRESS RELEASE
Sanofi`s Brivekimig Shows Positive Phase 2a Results
17 Sep 2025 //
GLOBENEWSWIRE
Sanofi`s Libtayo Combo Shows 5-Year Survival Gain in NSCLC
16 Sep 2025 //
INDPHARMAPOST
Sanofi becomes Latest Pharma to Hold fire on UK R&D Investments
16 Sep 2025 //
FIERCE BIOTECH
Sanofi: Total Voting Rights and Shares Update - August 2025
12 Sep 2025 //
GLOBENEWSWIRE
Sanofi Triumphs at 2025 Fierce Pharma Marketing Awards
11 Sep 2025 //
FIERCE PHARMA
Sanofi`s SAR402663 Granted Fast Track Status for Neovascular AMD
11 Sep 2025 //
PRESS RELEASE
Tzield Approved in China: 1st Therapy for Stage 2 Type 1 Diabetes
11 Sep 2025 //
PRESS RELEASE
Sanofi Creates `Celebrity Mom Squad` for Beyfortus RSV Drive
10 Sep 2025 //
FIERCE PHARMA
Vyome Holdings Bolsters Team for Pivotal Trial Studies
09 Sep 2025 //
PHARMAWEB
Onco360® Chosen as National Pharmacy Partner for Wayrilz
08 Sep 2025 //
GLOBENEWSWIRE
Expert Discusses Future Research and Definitions in CIDP Care
08 Sep 2025 //
FIERCE PHARMA
New Data across Sanofi’s Immunology Pipeline reinforce leadership
05 Sep 2025 //
PRESS RELEASE
Sanofi Ph 3 Eczema Win Falls Below Analyst Expectations
04 Sep 2025 //
FIERCE BIOTECH
Thermo Fisher Scientific Buys NJ Site from Sanofi
02 Sep 2025 //
PRESS RELEASE
Genzyme`s Wayrilz Receives Approval in US
29 Aug 2025 //
FDA
Sanofi`s Wayrilz FDA Approved as First BTK Inhibitor for Immune
29 Aug 2025 //
PRESS RELEASE
Sanofi Joins Report Spotlighting Community Health Workers
27 Aug 2025 //
FIERCE PHARMA
Sanofi snags BioMarin Leader to Serve as CMO
26 Aug 2025 //
FIERCE BIOTECH
